Baker Bros. Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
Baker Bros. Advisors's FLGT Position: Q4 2022 in Review
Baker Bros. Advisors sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 166,619 shares — an estimated $6.35M sold.
Baker Bros. Advisors first reported a position in FLGT in Q3 2016 and held it in 25 quarters. The position peaked at $38.7M in Q1 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.
- Baker Bros. Advisors reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
- Baker Bros. Advisors sold 166,619 Fulgent Genetics shares in Q4 2022, an estimated $6.35M.
- Baker Bros. Advisors first reported a position in Fulgent Genetics in Q3 2016 and held it in 25 quarters.
- Baker Bros. Advisors's Fulgent Genetics position peaked at $38.7M in Q1 2021.
- 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.
Based on Baker Bros. Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.